Breccia, Massimo https://orcid.org/0000-0003-1163-6162
Palandri, Francesca
Luciano, Luigiana
Benevolo, Giulia
Bonifacio, Massimiliano
Caocci, Giovanni
Castagnetti, Fausto
Palumbo, Giuseppe A.
Iurlo, Alessandra
Landi, Francesco
Funding for this research was provided by:
Novartis Italia (medical writing assistance was funded by Novartis, Italy)
Article History
Received: 10 November 2017
Accepted: 23 January 2018
First Online: 22 February 2018
Compliance with ethical standards
:
: M. Breccia is a consultant and received honoraria from Novartis, BMS, Pfizer, Incyte, and Celgene.F. Palandri received honoraria from Novartis.L. Luciano received honoraria from Novartis, BMS, Pfizer, and Incyte.G Benevolo received honoraria from Novartis and Janssen-Cilag.M. Bonifacio received research funding from Novartis and consultancy fees from Bristol-Myers Squibb, Pfizer, and Incyte.F. Castagnetti is a consultant for and has received honoraria from Novartis, Bristol-Myers Squibb, Pfizer, and Incyte.G.A. Palumbo is a consultant for Novartis, Italy.A. Iurlo is a consultant for and received honoraria from Novartis, Bristol-Myers Squibb, Incyte, and Pfizer.G. Caocci and F. Landi have no conflicts of interest to declare.